Objective: The aim of this study was to investigate the specificity and sensitivity of the conventional test combination used for the evaluation of the breast masses that included physical examination (PE), mammography (MG) and fine needle aspiration biopsy (FNAB) in evaluating the malignant or benign characteristics of the masses with respect to the data in our hospital, and to determine the specificity and sensitivity of alternative test combinations in order to compare the efficacy of these combinations.
Introduction
Breast cancer continues to be the leading cause of cancer-related morbidity and mortality among women today. Early diagnosis and treatment, besides being life-saving, reduces morbidity (1) . Various examinations, interventions or their combinations are used for early diagnosis. While an accurate and adequate examination, according to the characteristics of the lesion and the patient's age, increases the cancer detection rate, it also minimizes unnecessary tests and interventions (2) .
Effectiveness of the Triple Test and Its Alternatives for Breast Mass Evaluation Meme Kitlelerini Değerlendirmede Üçlü Test ve Alternatiflerinin Etkinliği
Murat Baykara A solid mass detected on physical examination (PE) of a woman, over the age of 40 years, should be considered a potential cancer unless proven otherwise, and tests should be planned in order to exclude this possibility. In these circumstances, the first procedure should be mammography (MG) followed by fine needle aspiration biopsy (FNAB) (3) . On the other hand, MG is not useful in women under the age of 40 due to the more dense breast pattern and these patients should be evaluated with ultrasonography. PE may be repeated at 2-4 month intervals if the mass cannot be identified with ultrasonography (US) (4) . In addition, MG may be useful for women between the ages 35-40 if US reveals normal or suspicious findings. In the presence of a mass having benign properties on PE, the decision for excision or PE follow up can be made with the patients' and surgeon's shared judgment. FNAB and US should be performed in order to verify that masses, which are planned to be followed clinically, are benign (5) . The Triple test (TT), which has been widely used over the past 30 years in women over 40 who have a mass on PE, is accepted as the best combination to detect the characteristics of a mass. This test is based on the correlation of these three parameters: physical examination, mammography and fine needle aspiration biopsy (5, 6) . The diagnostic accuracy of the TT reaches 100% if all three tests indicate benign or malignant findings in a palpable mass (7) (8) (9) . In some studies, similar accuracy rates have also been obtained in non-palpable masses (10) .
In this study, the correlation of the standard TT, composed of PE, MG and FNAB, and different triple test groupings were evaluated, calculations of sensitivity and specificity were made and the effectiveness of different TTs in the assessment of breast masses were investigated.
Materials and Methods
Of the 6243 women who were admitted to the Cancer Early Diagnosis, Screening and Education Center for breast cancer screening between January 2004 and December 2009, the data of 636 patients who were detected to have a breast mass were retrospectively analysed. The history, physical examination and mammography and ultrasonography findings of the patients were evaluated. All patients had physical examinations, imaging methods and FNAB, and 448 cases who had suspicious masses and consented had excisional biopsies. Mammographic and ultrasongraphic evaluation was performed by two radiologists according to the BI-RADS criteria (11) . FNAB were performed under US guidance and excisional biopsies were carried out in the General Surgery Clinic and evaluated by a pathologist. The accuracy of the triple tests was verified pathologically in the 448 patients who had excisional biopsies and with a 3-year follow up in the remainder of the patients.
Patients were evaluated with the standard TT, PE+MG+FNAB and additionally with the alternative TT combinations of PE+US+FNAB, PE+MG+US and MG+US+FNAB. The standards in the literature were used for assessment (12) .
Statistical analysis
Sensitivity, specificity, positive predictive and negative predictive values were calculated from the obtained data and comparatively evaluated.
Results
The median age of the 636 women was 55 years (38-76). The individual values found for each analysis method and triple test are presented in Table 1-8. First of all, every patient was evaluated with each diagnostic test. Then the final diagnosis with excisional biopsy and long term follow up was compared and the values of true positive (TP), false positive (FP), false negative (FN), true negative (TN), sensitivity (Sn), specificity (Sp), positive predictive (PP) and negative predictive (NP) were calculated. Cases defined as 'intermediate' in the table were the suspicious cases where the determination of benign or malignant could not be made. These cases were not included in the calculations. As none of the cases that were detected to have a mass on physical examination were considered to be definitely benign, all cases except those thought to be malignant were included in the suspicious (main) group (Table 1) . Evaluations with mammography, ultrasonography and FNAB decreased the number of patients in the intermediate group but were observed to not be enough individually (Table 2-4).
Sn was 100% and Sp was 92.1% with the classical triple test (PE+MG+FNAB) and these ratios were observed to be quite high (Table 5) . On the other hand, the Sn and Sp for our newly described triple test, PE+MG+US and MG + US + FNAB were 100% and 91.8%, respectively (Table 6 ).
Of these triple tests, MG+US+FNAB was found to have the highest diagnostic accuracy with a Sn and Sp of 100% (Table 7) .
Discussion and Conclusions
The examination including PE, MG and FNAB, which is known as the triple test, was first described in 1975 and in recent years is the most preferred and widely used for diagnosis of palpable masses in women over the age of 40 years (5, 6, 13, 14) . Reports are available stating that the diagnostic accuracy of TT is 100% when the three parameters are benign or malignant (8, 9, 14) . The same accuracy rates were also obtained with the TT in non-palpable breast masses (10) . With the TT, the possibility of a mass with benign characteristics being malignant is about 0.6-0.7% and studies have shown that these masses may be followed safely without performing more invasive procedures when all three parameters are benign (6, (14) (15) (16) (17) (18) . In the review presented by Irwig et al. (19) , the sensitivity of PE, MG and FNAB were found to be 85%, 90% and 91% respectively and specificity was found to be 80%, 73% and 93%, respectively for 735 cancer cases and 1128 non-cancer cases (19) .
In a large series published by Ciatto et al. (20) , the sensitivity of the TT was reported as being 99.7%. In the study of Steinberg et al. (14) , the components of the TT were studied both individually and in combination and compared with open biopsy. Sensitivity was found to be 95.5%, specificity 100%, positive predictive value 100% and negative predictive value 98.3% in the combined TT (12). Morris et al. (4) developed TT and formed a TT score for each parameter called 1, 2 and 3 according to the mass being benign, suspicious or malignant (12) . A total score of 3-4 was defined as being benign (benign triple), 5 as being benign or malignant lesions (mixed triple) and 6-9 as being malignant (malignant triple). who had a breast mass on physical examination underwent excision for histological verification and all 130 cases that had a score of 5 or above were found to be malignant. As a result of this study, the authors suggested that follow up and definite treatment may be safely planned without the need for biopsy by TT scoring in 92% of cases in the presence of a palpable mass in women over the age of 40 (12, 16) . The ratio of cases having open biopsy was reduced to 8% from 40% with the standard TT scoring method (3, 12) .
In our study, the sensitivity of the standard TT was found to be 51.85% and the specificity to be 91.43%. When these values were compared with the literature, the sensitivity was particularly low. This may have been due to the physicians who evaluated the patients; they may not have been especially experienced on this issue.
The most important problems with the TT are the reliability /accuracy and the applicability by different centers or clinics. Clinics that use the classical TT or the modified scoring system are recommended to evaluate the accuracy rates of each parameter of the test and interpret the TT results according to this. Clinical follow up at 6 months can be advised when all three parameters of the TT are benign (12, 16) . When the mass is considered to be malignant based on PE, MG and FNAB, definite treatment (radical surgical intervention or neoadjuvant therapy with or without frozen section) may be planned. If there is any inconsistency between PE, MG, US and FNAB, in other words when a definite discrimination of benign or malignant cannot be made, definite treatment should not be planned without histopathology verification (open biopsy/intraoperative biopsy) (9, 12, 16, 21) . Besides modifying the scoring of the classic TT, recently different TTs have come into question (12, 19, 22, 23) . In these modified tests, US has been recommended instead of mammography in women under the age of 40 and core biopsy (classical or vacuum-assisted) has been recommended as an alternative or an addition to FNAB (12, 19) .
In this study, we calculated the sensitivity and specificity of PE+US+FNAB and US+MG+FNAB combinations as possible alternatives to the classical TT. According to our findings, which are seen in detail in Table 6 , 7 and 8, the combination which has the highest specificity (100%) and sensitivity (100%) is the trio of US+MG+FNAB.
According to these results, we believe that the findings of physical examinations do not provide data as reliable as those of imaging methods for the discrimination of benign or malignant masses. Certainly, physical examination is a necessary method as it is a simple, inexpensive and easily applicable method and it provides communication with the patient to detect the presence of a mass. However, its effectiveness is very low in determining whether the mass is malignant or benign. Therefore, additional imaging methods should certainly be performed in the presence of a suspicious mass on physical examination.
Imaging methods have great importance for the assessment of breast masses. US or MG may not be sufficient alone for the evaluation of malignity in women over 40. We believe that the treatment of a mass may be possible without the need for more invasive method by using imaging methods supported with FNAB findings.
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